FDA — authorised 30 January 2004
- Application: NDA021540
- Marketing authorisation holder: PHARMACIA
- Local brand name: CADUET
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Amlodipine/Atorvastatin on 30 January 2004
Yes. FDA authorised it on 30 January 2004.
PHARMACIA holds the US marketing authorisation.